Doorgaan naar hoofdnavigatie
Doorgaan naar zoeken
Ga verder naar hoofdinhoud
Sorteer per
Keyphrases
Diffuse Intrinsic Pontine Glioma
100%
Tumor
21%
Pediatric Glioma
18%
Radiotherapy
14%
Childhood Brain Tumor Survivors
13%
Medulloblastoma
13%
Glioma Cells
13%
Focused Ultrasound
13%
Pediatric Brain Tumor
13%
High-grade Glioma
12%
Glioma Patients
12%
Brain Tumor
12%
Diffuse Midline Glioma
11%
Blood-brain Barrier
10%
Pediatric
10%
Pons
9%
89Zr-bevacizumab
9%
Pediatric Brain Tumor Survivors
9%
Drug Delivery
9%
Hypothalamic-pituitary Dysfunction
8%
Bevacizumab
8%
Convection-enhanced Delivery
8%
Clinical Trials
8%
Patient-derived Xenograft
8%
Netherlands
7%
Risk Factors
7%
Molecular Diagnostics
7%
Brainstem
7%
Radiosensitization
7%
Neurocognitive Complaints
7%
Treatment Strategy
7%
Disease Progression
7%
Survivors
7%
Central Nervous System Tumors
6%
Meta-analysis
6%
Healthcare Professionals
6%
Working Diagnosis
6%
Neuroblastoma
6%
Re-irradiation
6%
Liquid Biopsy
6%
Population-based Study
6%
Survival Prediction Model
6%
Endocrine Disorders
6%
European Society
6%
WHO Classification of CNS Tumors
6%
Pediatric Oncology
6%
Prevalence Factors
6%
International Survey
6%
Overall Survival
6%
Autopsy
5%
Medicine and Dentistry
Pontine Glioma
77%
Ganglioglioma
56%
Pediatrics
40%
Neoplasm
36%
Central Nervous System Tumor
21%
Intracranial Tumor
17%
Childhood Cancer
16%
Tumor
16%
In Vitro
14%
Xenograft
12%
Clinical Trial
11%
Biopsy Technique
11%
Glioma Cell
9%
Overall Survival
9%
Ganglioneuroblastoma
8%
Medulloblastoma
8%
Disease
8%
Radiation Therapy
7%
Ependymoma
7%
Blood Brain Barrier
7%
Tumor Cell
7%
Liquid Biopsy
6%
Radiosensitization
6%
Molecular Diagnostics
6%
Cell Invasion
6%
Cohort Analysis
6%
Bevacizumab
6%
Brainstem
6%
Pilocytic Astrocytoma
6%
Pediatric Brain Tumor
6%
Adolescence
5%
Tumor Progression
5%
Malignant Neoplasm
5%
Survival Rate
5%
Pons
5%
Disease Exacerbation
5%
Radiation Therapy
5%
Progression Free Survival
5%
Olaparib
5%
